255 related articles for article (PubMed ID: 18316574)
1. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
Lou Y; Basha G; Seipp RP; Cai B; Chen SS; Moise AR; Jeffries AP; Gopaul RS; Vitalis TZ; Jefferies WA
Clin Cancer Res; 2008 Mar; 14(5):1494-501. PubMed ID: 18316574
[TBL] [Abstract][Full Text] [Related]
2. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
[TBL] [Abstract][Full Text] [Related]
4. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
[TBL] [Abstract][Full Text] [Related]
5. A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression.
Garbi N; Tiwari N; Momburg F; Hämmerling GJ
Eur J Immunol; 2003 Jan; 33(1):264-73. PubMed ID: 12594855
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.
Setiadi AF; Omilusik K; David MD; Seipp RP; Hartikainen J; Gopaul R; Choi KB; Jefferies WA
Cancer Res; 2008 Dec; 68(23):9601-7. PubMed ID: 19047136
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
8. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells.
Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG
J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476
[TBL] [Abstract][Full Text] [Related]
9. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes.
Hung CF; Cheng WF; He L; Ling M; Juang J; Lin CT; Wu TC
Cancer Res; 2003 May; 63(10):2393-8. PubMed ID: 12750257
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading.
Tan P; Kropshofer H; Mandelboim O; Bulbuc N; Hämmerling GJ; Momburg F
J Immunol; 2002 Feb; 168(4):1950-60. PubMed ID: 11823531
[TBL] [Abstract][Full Text] [Related]
11. Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading.
Peh CA; Laham N; Burrows SR; Zhu Y; McCluskey J
J Immunol; 2000 Jan; 164(1):292-9. PubMed ID: 10605023
[TBL] [Abstract][Full Text] [Related]
12. Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1.
Lou Y; Seipp RP; Cai B; Chen SS; Vitalis TZ; Choi KB; Jeffries AP; Gopaul RS; Li XL; Seliger B; Pearson TW; Jefferies WA
Vaccine; 2007 Mar; 25(12):2331-9. PubMed ID: 17229499
[TBL] [Abstract][Full Text] [Related]
13. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.
Wolpert EZ; Petersson M; Chambers BJ; Sandberg JK; Kiessling R; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11496-501. PubMed ID: 9326638
[TBL] [Abstract][Full Text] [Related]
14. TAP expression provides a general method for improving the recognition of malignant cells in vivo.
Alimonti J; Zhang QJ; Gabathuler R; Reid G; Chen SS; Jefferies WA
Nat Biotechnol; 2000 May; 18(5):515-20. PubMed ID: 10802618
[TBL] [Abstract][Full Text] [Related]
15. Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma.
Agrawal S; Reemtsma K; Bagiella E; Oluwole SF; Braunstein NS
Cell Immunol; 2004 Apr; 228(2):130-7. PubMed ID: 15219464
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
17. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
Hulpke S; Baldauf C; Tampé R
FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
[TBL] [Abstract][Full Text] [Related]
18. Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors.
Qin Z; Harders C; Cao X; Huber C; Blankenstein T; Seliger B
Cancer Res; 2002 May; 62(10):2856-60. PubMed ID: 12019164
[TBL] [Abstract][Full Text] [Related]
19. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
[TBL] [Abstract][Full Text] [Related]
20. Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.
Suh WK; Derby MA; Cohen-Doyle MF; Schoenhals GJ; Früh K; Berzofsky JA; Williams DB
J Immunol; 1999 Feb; 162(3):1530-40. PubMed ID: 9973410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
